2009 Annual Meeting | Neurodevelopmental Disabilities Across the Lifespan

Date Wednesday 04/29/09

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Max Wiznitzer, MD, FAAN

Topic(s)

Learning Objectives Participants should be able to recognize the clinical features of the discussed NDDs throughout the lifespan; understand their neurobiologic basis and core neuropsychological underpinnings and impact on clinical manifestations; and know the available assessment and intervention options (medication and nonpharmacologic) at various ages for the discussed NDDs and associated comorbid disorders.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
02:15 PM - 02:30 PM		Prevalence and Epidemiology of the Neurodevelopmental Disabilities Max Wiznitzer, MD, FAAN
02:30 PM - 03:30 PM		Brain Development: Normal and Abnormal Aspects Max Wiznitzer, MD, FAAN
03:30 PM - 03:45 PM		Break
03:45 PM - 04:30 PM		Cerebral Palsy Ann H. Tilton, MD, FAAN
04:30 PM - 05:15 PM		Epilepsy and Development Monisha Goyal, MD
05:15 PM - 06:00 PM		Autism Spectrum Disorders Max Wiznitzer, MD, FAAN

Faculty Disclosures
Max Wiznitzer, MD, FAAN	Dr. Wiznitzer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Department of Health and Human Services - Vaccine Injury Compensation Program. Dr. Wiznitzer has a non-compensated relationship as a Board of Directors with CHADD that is relevant to AAN interests or activities.
Michael V. Johnston, MD	No disclosure on file
Ann H. Tilton, MD, FAAN	Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for allergan. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Dr. Tilton has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Keane law firm - Defense.
Monisha Goyal, MD	Dr. Goyal has nothing to disclose.

��ɫ��

��ɫ��